Filing
2nd Quarter - Amendment
Lobbying activity
3
Issues related to CMS reimbursement.
Issues related to CMS reimbursement.
Issues related to CMS reimbursement. FDA issues.
Issues related to CMS reimbursement.
Issues related to CMS reimbursement.
Issues related to CMS reimbursement. FDA issues.